Alabama
Birmingham; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
California
San Francisco; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Florida
Tampa; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Georgia
Atlanta; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Illinois
Chicago; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Chicago; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Massachusetts
Boston; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Boston; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Michigan
Detroit; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
New York
New York; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
North Carolina
Durham; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Durham; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Ohio
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase I Study of Vinblastine in Combination with Carboplatin for Children with Newly Diagnosed and Recurrent Low Grade Gliomas
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection
Cleveland; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Pennsylvania
Philadelphia; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Pittsburgh; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Tennessee
Memphis ; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Texas
Houston; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Houston; GSK Clinical Trials Call Center
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Washington
Seattle; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
Washington, DC
Washington; Research Site:
A Study of Xeloda (Capecitabine) plus Radiation Therapy in Children With Newly Diagnosed Gliomas
